Biological prosthetic valve thrombosis

Abstract

Bioprosthetic valve thrombosis was considered a relatively rare entity. However, due to the increased use of bioprostheses in cardiac surgery and the advent of transcatheter biological prostheses, it has acquired more attention as a cause of prosthetic dysfunction. The long-term relevance of subclinical thrombosis has not yet been elucidated, nor are the optimal therapeutic strategies to prevent bioprosthetic valve thrombosis or thromboembolic complications. This review aims to provide a summary of the pathophysiology, diagnosis and treatment of bioprosthetic valve thrombosis to contribute to the knowledge of this pathology.